Loading data for PMVP — first visit, this takes a few seconds.
PMV Pharmaceuticals Inc. (PMVP)
NasdaqGS: PMVP
· Real-Time Price · USD
1.33
+0.03 (2.31%)
At close: Aug 25, 2026, 8:00 PM
The price, the headline numbers and the latest news, in one place.
PMV Pharmaceuticals Inc. (PMVP) Stock Price, Analysis & Data
2.31% (1D)
No data available
| Bid | 0.94 |
| Market Cap | 69.76M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -75.22M |
| 1.35 | |
| -1.43 | |
| n/a | |
| -1.14 | |
| P/B (ttm) | 0.98 |
| P/S (ttm) | n/a |
| Earnings Date | Nov 16, 2026 |
| Ask | 1.68 |
| Volume | 131,308 |
| Avg. Volume (20D) | 312,579 |
| Open | 1.32 |
| Previous Close | 1.30 |
| Day's Range | 1.30 - 1.34 |
| 52-Week Range | 1.02 - 1.88 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About PMVP
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in ...
Industry Biotechnology
Sector Healthcare
IPO Date Sep 25, 2020
Employees 54
Stock Exchange NasdaqGS
Ticker Symbol PMVP
Website https://www.pmvpharma.com
Financial Performance
In 2025, PMV Pharmaceuticals's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -77.74M, an increase of 32.42%.
Financial StatementsEarnings Surprise
PMV Pharmaceuticals has released their quarterly earnings on Aug 14, 2026:
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of -0.34 exceeds estimates by 0.06, with 17.07% YoY growth.
PMV Pharmaceuticals Inc. is scheduled to release its earnings on Nov 16, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2